Riverwater Partners LLC Acquires Shares of 10,585 Amrize Ltd $AMRZ

Riverwater Partners LLC bought a new position in Amrize Ltd (NYSE:AMRZFree Report) during the third quarter, Holdings Channel.com reports. The institutional investor bought 10,585 shares of the company’s stock, valued at approximately $514,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Mutual of America Capital Management LLC acquired a new stake in shares of Amrize in the third quarter valued at approximately $4,519,000. Cullen Frost Bankers Inc. increased its stake in shares of Amrize by 126.4% in the 3rd quarter. Cullen Frost Bankers Inc. now owns 11,062 shares of the company’s stock worth $537,000 after acquiring an additional 6,176 shares during the last quarter. CIBC Asset Management Inc acquired a new stake in shares of Amrize in the 3rd quarter worth $291,000. LB Partners LLC purchased a new position in shares of Amrize during the 3rd quarter worth $485,000. Finally, Hunter Associates Investment Management LLC acquired a new position in shares of Amrize during the 3rd quarter valued at about $511,000.

Insider Buying and Selling at Amrize

In other Amrize news, CEO Jan Philipp Jenisch bought 55,000 shares of Amrize stock in a transaction on Thursday, October 30th. The shares were bought at an average cost of $52.64 per share, for a total transaction of $2,895,200.00. Following the acquisition, the chief executive officer directly owned 1,505,000 shares in the company, valued at $79,223,200. This represents a 3.79% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Nicholas C. Gangestad purchased 2,000 shares of the firm’s stock in a transaction on Wednesday, November 19th. The stock was acquired at an average cost of $47.34 per share, with a total value of $94,680.00. Following the transaction, the director directly owned 4,958 shares in the company, valued at $234,711.72. This trade represents a 67.61% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders acquired a total of 65,000 shares of company stock worth $3,399,720 over the last ninety days.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on the stock. Wells Fargo & Company upped their price objective on shares of Amrize from $57.00 to $58.00 and gave the company an “overweight” rating in a report on Thursday, October 30th. UBS Group increased their price target on shares of Amrize from $53.00 to $57.00 and gave the company a “neutral” rating in a research note on Thursday, January 8th. Wall Street Zen raised shares of Amrize to a “hold” rating in a research report on Saturday, October 25th. Oppenheimer increased their price objective on Amrize from $62.00 to $64.00 and gave the stock an “outperform” rating in a research report on Thursday, January 15th. Finally, Oddo Bhf started coverage on Amrize in a research note on Monday, November 3rd. They set a “neutral” rating for the company. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, Amrize has a consensus rating of “Moderate Buy” and an average target price of $60.67.

Read Our Latest Report on Amrize

Amrize Stock Up 0.5%

Shares of NYSE AMRZ opened at $54.49 on Tuesday. Amrize Ltd has a 52-week low of $44.12 and a 52-week high of $58.11. The firm has a 50 day moving average price of $53.75. The stock has a market capitalization of $30.14 billion and a price-to-earnings ratio of 29.61. The company has a current ratio of 1.45, a quick ratio of 0.97 and a debt-to-equity ratio of 0.38.

Amrize (NYSE:AMRZGet Free Report) last posted its earnings results on Wednesday, October 29th. The company reported $0.98 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.01 by ($0.03). The company had revenue of $3.68 billion during the quarter, compared to analysts’ expectations of $3.49 billion. The company’s revenue for the quarter was up 6.6% on a year-over-year basis.

Amrize Profile

(Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Featured Articles

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZFree Report).

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.